News Summary: Mylan to buy Agila for $1.6 billion
Published: February 27, 2013
Leave a comment
THE DEAL: Mylan Inc., one of the world's largest maker of generic drugs, is buying Agila Specialties of India for $1.6 billion to expand its offerings of injectable drugs and boost its sales in emerging markets.
Advertisement
THE RESULTS: The Pittsburgh company also reported a 25 percent increase in fourth-quarter net income on double-digit revenue growth. Mylan earned 39 cents per share, or 65 cents per share excluding items, a penny ahead of expectations.
THE FORECAST: Mylan forecast adjusted income of $2.75 to $2.95 per share and revenue of $7 billion to $7.4 billion for 2013. Analysts expect earnings per share of $2.81 on revenue of $7.14 billion.
If you prefer your thoughts to appear in The Oklahoman's Opinion section, we encourage you to submit a letter to the editor.
Mortgage Rates Hit 2.50%
White House Program Cuts Up to $1k off Monthly Payments! (2.90% APR)
www.SeeRefinanceRates.com
White House Program Cuts Up to $1k off Monthly Payments! (2.90% APR)
www.SeeRefinanceRates.com
Woman is 57 But Looks 25
Mom reveals simple wrinkle secret that has angered doctors...
www.HealthJournalsReview.com
Mom reveals simple wrinkle secret that has angered doctors...
www.HealthJournalsReview.com
Prev
